anzatax 0.5mg tableta
eurofarma peru s.a.c. - laboratorio - clonazepam; - tableta - por tableta - - clonazepam
anzatax 2mg tableta
eurofarma peru s.a.c. - laboratorio - clonazepam; - tableta - por tableta - - clonazepam
anzatax 2mg tableta
eurofarma peru s.a.c. - tableta
anzatax 0.5mg tableta
eurofarma peru s.a.c. - tableta
anzatax 0,5 mg tabletas
casa de representacion inversiones arkomedic s.a. - clonazepam - tableta - 0.5mg(a5)-c
anzatax 2 mg tabletas
casa de representacion inversiones arkomedic s.a. - clonazepam - tableta - 2 mg (a5)-c
plerixafor glenmark 20 mg/ml solucion inyectable efg
glenmark arzneimittel gmbh - plerixafor - soluciÓn inyectable - 20 mg/ml inyectable 1,2 ml - plerixafor 20 mg - plerixafor
plerixafor accord
accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - inmunoestimulantes, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.
mozobil
sanofi b.v. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation; lymphoma - inmunoestimulantes, - mozobil está indicado en combinación con el factor estimulante de colonias de granulocitos para mejorar la movilización de células de madre hematopoyéticas a sangre periférica para la recogida y posterior trasplante autólogo en pacientes con linfoma y múltiples mieloma cuyas células movilizan mal.
kandoset 16 mg/5 mg comprimidos
krka d.d. novo mesto - candesartan cilexetilo; amlodipino besilato - comprimido - 16 mg/5 mg - candesartan cilexetilo 16 mg; amlodipino besilato 5 mg - candesartan y amlodipino